METABOLIC PROFILE CHANGES IN SERUM OF MIGRAINE PATIENTS DETECTED USING 1H-NMR SPECTROSCOPY 45 2 46. Nicholson JK, Foxall PJD, Spraul M, Farrant RD, Lindon JC. 750-Mhz H-1 and H-1-C-13 Nmr-Spectroscopy of Human Blood-Plasma. Anal Chem. 1995;67(5):793-811. 47. MacIntyre DA, Jimenez B, Lewintre EJ, et al. Serum metabolome analysis by H-1NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. Leukemia. 2010;24(4):788-797. 48. Tomasi G, van den Berg F, Andersson C. Correlation optimized warping and dynamic time warping as preprocessing methods for chromatographic data. J Chemometr. 2004;18(5):231-241. 49. Wishart DS, Jewison T, Guo AC, et al. HMDB 3.0-The Human Metabolome Database in 2013. Nucleic Acids Res. 2013;41(D1):D801-D807. 50. Aulchenko YS, Ripke S, Isaacs A, Van Duijn CM. GenABEL: an R library for genomewide association analysis. Bioinformatics. 2007;23(10):1294-1296. 51. Friedman J, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010;33(1):1-22. 52. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006;67(2):252-257. 53. Linstra KM, Ibrahimi K, Terwindt GM, Wermer MJ, MaassenVanDenBrink A. Migraine and cardiovascular disease in women. Maturitas. 2017;97:28-31. 54. Tietjen GE,Khubchandani J.Vascular biomarkers in migraine. Cephalalgia. 2015;35(2):95-117. 55. Onderwater GLJ, Ligthart L, Bot M, et al. Large-scale plasma metabolome analysis reveals alterations in HDL metabolism in migraine. Neurology. 2019;92(16):e1899-e1911. 56. Rubino E, Vacca A, Govone F, et al. Investigating the role of adipokines in chronic migraine. Cephalalgia. 2017;37(11):1067-1073. 57. Bigal ME, Kurth T, Hu H, Santanello N, Lipton RB. Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology. 2009;72(21):1864-1871. 58. Paolucci M, Altamura C, Vernieri F. The Role of Endothelial Dysfunction in the Pathophysiology and Cerebrovascular Effects of Migraine: A Narrative Review. J Clin Neurol. 2021;17(2):164-175. 59. Rainero I, Govone F, Gai A, Vacca A, Rubino E. Is Migraine Primarily a Metaboloendocrine Disorder? Curr Pain Headache Rep. 2018;22(5):36. 60. Yorns WR, Jr., Hardison HH. Mitochondrial dysfunction in migraine. Semin Pediatr Neurol. 2013;20(3):188-193. 61. Burch RC, Rist PM, Winter AC, et al. Migraine and risk of incident diabetes in women: a prospective study. Cephalalgia. 2012;32(13):991-997. 62. López-de-Andrés A, Luis Del Barrio J, Hernández-Barrera V, et al. Migraine in adults with diabetes; is there an association? Results of a population-based study. Diabetes Metab Syndr Obes. 2018;11:367-374. 63. Cavestro C, Rosatello A, Micca G, et al. Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Headache. 2007;47(10):1436-1442. 64. Rainero I, Limone P, Ferrero M, et al. Insulin sensitivity is impaired in patients with migraine. Cephalalgia. 2005;25(8):593-597. 65. Zhang DG, Amin FM, Guo S, et al. Plasma Glucose Levels Increase During Spontaneous Attacks of Migraine With and Without Aura. Headache. 2020;60(4):655-664. 66. Okada H, Araga S, Takeshima T, Nakashima K. Plasma lactic acid and pyruvic acid levels in migraine and tension-type headache. Headache. 1998;38(1):39-42. 67. Batch BC, Hyland K, Svetkey LP. Branch chain amino acids: biomarkers of health and disease. Curr Opin Clin Nutr Metab Care. 2014;17(1):8689. 68. Domitrz I, Koter MD, Cholojczyk M, et al. Changes in Serum Amino Acids in Migraine Patients without and with Aura and their Possible Usefulness in the Study of Migraine Pathogenesis. CNS Neurol Disord Drug Targets. 2015;14(3):345-349.
RkJQdWJsaXNoZXIy MTk4NDMw